76 related articles for article (PubMed ID: 7804197)
1. Sensitivity of taxonomically diverse fungi to pentamidine isethionate.
Ludewig G; Staben C
J Eukaryot Microbiol; 1994; 41(5):103S. PubMed ID: 7804197
[No Abstract] [Full Text] [Related]
2. Pentamidine sensitivity and resistance in Saccharomyces cerevisiae as a model for pentamidine effects on Pneumocystis carinii.
Hatfield C; Kasarskis A; Staben C
J Protozool; 1991; 38(6):70S-71S. PubMed ID: 1818214
[TBL] [Abstract][Full Text] [Related]
3. Extent of fungal contamination in rat-derived Pneumocystis carinii extracts and the effect on uptake of para-aminobenzoic acid.
Chung V; Shah K
J Eukaryot Microbiol; 1994; 41(5):80S-81S. PubMed ID: 7804277
[No Abstract] [Full Text] [Related]
4. Development of pentamidine analogues as new agents for the treatment of Pneumocystis carinii pneumonia.
Tidwell RR; Jones SK; Geratz JD; Ohemeng KA; Bell CA; Berger BJ; Hall JE
Ann N Y Acad Sci; 1990; 616():421-41. PubMed ID: 2078033
[No Abstract] [Full Text] [Related]
5. Mutation of the mitochondrial large ribosomal RNA can provide pentamidine resistance to Saccharomyces cerevisiae.
Örs ŞT; Akdoğan E; Dunn CD
Mitochondrion; 2014 Sep; 18():7-11. PubMed ID: 25151477
[TBL] [Abstract][Full Text] [Related]
6. Antimycotic effects of octenidine and pirtenidine.
Ghannoum MA; Elteen KA; Ellabib M; Whittaker PA
J Antimicrob Chemother; 1990 Feb; 25(2):237-45. PubMed ID: 2184158
[TBL] [Abstract][Full Text] [Related]
7. Enhanced efficacy of a liposomal pentamidine preparation in Pneumocystis carinii in an ex vivo/in vitro culture model without feederlayer cells.
Sahm M; Wingen F; Hager J; Seitz HM
Appl Parasitol; 1996 Jun; 37(2):137-45. PubMed ID: 8688862
[TBL] [Abstract][Full Text] [Related]
8. Lack of effect of prophylactic aerosolized pentamidine on the detection of Pneumocystis carinii in induced sputum or bronchoalveolar lavage specimens.
Ng VL; Geaghan SM; Leoung G; Shiboski S; Fahy J; Schnapp L; Yajko DM; Hopewell PC; Hadley WK
Arch Pathol Lab Med; 1993 May; 117(5):493-6. PubMed ID: 8489338
[TBL] [Abstract][Full Text] [Related]
9. Evolution of antifungal-drug resistance: mechanisms and pathogen fitness.
Anderson JB
Nat Rev Microbiol; 2005 Jul; 3(7):547-56. PubMed ID: 15953931
[TBL] [Abstract][Full Text] [Related]
10. [Hydrochloric acid tolerance of Candida albicans].
Meinhof W
Mykosen; 1974 Dec; 17(12):339-47. PubMed ID: 4614092
[No Abstract] [Full Text] [Related]
11. In-vitro susceptibility of Candida albicans and Candida stellatoidea to sulfamethoxazole.
Kamaya T
Mycopathol Mycol Appl; 1973 Mar; 49(2):193-200. PubMed ID: 4571243
[No Abstract] [Full Text] [Related]
12. Effects of pentamidine isethionate on Saccharomyces cerevisiae.
Ludewig G; Williams JM; Li Y; Staben C
Antimicrob Agents Chemother; 1994 May; 38(5):1123-8. PubMed ID: 8067749
[TBL] [Abstract][Full Text] [Related]
13. The use of short-term cultures of Pneumocystis for drug testing.
Sahm M; Wingen F; Seitz HM
Appl Parasitol; 1996 Jan; 37(1):45-53. PubMed ID: 8574247
[TBL] [Abstract][Full Text] [Related]
14. U.S.-manufactured pentamidine isethionate cleared for investigational use.
Centers for Disease Control (CDC)
MMWR Morb Mortal Wkly Rep; 1984 May; 33(19):270. PubMed ID: 6425628
[No Abstract] [Full Text] [Related]
15. The MAP kinase-activated protein kinase Rck2p plays a role in rapamycin sensitivity in Saccharomyces cerevisiae and Candida albicans.
Li X; Huang X; Zhao J; Zhao J; Wei Y; Jiang L
FEMS Yeast Res; 2008 Aug; 8(5):715-24. PubMed ID: 18625027
[TBL] [Abstract][Full Text] [Related]
16. The choice of fungi as test organisms in disinfectant testing.
van de Voorde H; Reybrouck G; van Dijck P; Vranckx MJ
Zentralbl Bakteriol Mikrobiol Hyg B; 1984 May; 179(2):125-9. PubMed ID: 6377751
[TBL] [Abstract][Full Text] [Related]
17. Standardization of an in vitro drug screening assay by use of cryopreserved and characterized Pneumocystis carinii populations.
Collins MS; Cushion MT
J Eukaryot Microbiol; 2001; Suppl():178S-179S. PubMed ID: 11906052
[No Abstract] [Full Text] [Related]
18. [Antifungal resistance in opportunistic pathogenic fungi (II). Imidazoles and triazoles].
Martínez-Suárez JV; Rodríguez-Tudela JL
Enferm Infecc Microbiol Clin; 1996 Oct; 14(8):490-8. PubMed ID: 9011208
[No Abstract] [Full Text] [Related]
19. Growth and metabolism of Pneumocystis carinii in axenic culture.
Dis Markers; 1991; 9(1):55. PubMed ID: 1742950
[No Abstract] [Full Text] [Related]
20. Rational design of N-alkyl derivatives of 2-amino-2-deoxy-d-glucitol-6P as antifungal agents.
Melcer A; Łacka I; Gabriel I; Wojciechowski M; Liberek B; Wiśniewski A; Milewski S
Bioorg Med Chem Lett; 2007 Dec; 17(23):6602-6. PubMed ID: 17920268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
